Unibest
← Back to patent-cliff list

P4M-01

Tier C — Watch / trade

P4M-01

P4 Microbiome
Originator
-
First approval
-
Expiry (public)
No sales data
Peak sales
Small molecule
Type

Targets:Not applicable

Indications (approved):牙龈炎, 肠道疾病, 牙周疾病, Inflammatory bowel disease, 自然流产

Regional status

US
Phase II
2024-05-01
EU
-
China
-
Japan
-

Synthetic routes & intermediates

Routes not yet onboarded — the daily pipeline enriches by priority (approved small molecules first); this page updates automatically.

Frequently asked questions

What are the approved indications of P4M-01?

Approved indications include: 牙龈炎, 肠道疾病, 牙周疾病, Inflammatory bowel disease, 自然流产.

When does the P4M-01 patent expire?

No public expiry year is available for P4M-01 yet; this page updates once verified.

How do I get a quote for P4M-01 intermediates?

Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.

Source: cross-verified data (structured fields only) · 2026-10-01